CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- FinancialsAltman Z-Score 13.61: safe zone
- Interpretations7 currently firing — 7
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.81%
Annual Rate
CNY 0.46Paid annual
Payout Ratio
33.0%Sustainable
Last Ex-Dividend
Jun 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.07BCNY906.39M · vs all stocks (USD)
Trailing P/E
40.71xvs Medical Instruments & Supplies peers
Revenue (TTM)
1.13BCNY168.73M · vs all stocks (USD)
Profit Margin
18.46%vs Medical Instruments & Supplies peers
Beta
0.9280xvs all stocks
52-Week Change
79.63%vs all stocks
Market Capitalization
6.07BCNY906.39M · vs all stocks (USD)
Enterprise Value
7.04BCNY1.05B · vs all stocks (USD)
Trailing P/E
40.71xvs Medical Instruments & Supplies peers
Forward P/E
20.24xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
7.52xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.89xvs Medical Instruments & Supplies peers
Enterprise to Revenue
6.23xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
29.02xvs Medical Instruments & Supplies peers
Gross Margin
52.97%vs Medical Instruments & Supplies peers
Profit Margin
18.46%vs Medical Instruments & Supplies peers
Operating Margin
19.97%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
5.32%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
9.88%vs Medical Instruments & Supplies peers
Revenue (TTM)
1.13BCNY168.73M · vs all stocks (USD)
Revenue per Share (TTM)
7.55CNYUpdated Sep 21, 2026Quarterly Revenue Growth
15.70%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
594.17MCNY88.66M · vs all stocks (USD)
EBITDA (TTM)
254.60MCNY37.99M · vs all stocks (USD)
Net Income (TTM)
208.69MCNY31.14M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
9.00%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
232.27MCNY34.66M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
72.45MCNY10.81M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.4600CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
0.81%vs all stocks
Payout Ratio
32.99%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
13.34MCNYFY2025 · Dec 31, 2025Revenue
1.03BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
490.97MCNYFY2025 · Dec 31, 2025Gross Profit
543.81MCNYFY2025 · Dec 31, 2025Operating Income
186.78MCNY27.87M · vs all stocks (USD)
Pre-tax Income
216.18MCNYFY2025 · Dec 31, 2025Income Tax Expense
19.88MCNYFY2025 · Dec 31, 2025Net Income
196.29MCNYFY2025 · Dec 31, 2025EBIT
216.65MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
259.86MCNYFY2025 · Dec 31, 2025Research & Development
73.59MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
116.74MCNYFY2025 · Dec 31, 2025Other Operating Expenses
9.14MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
5.77MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
467.10KCNYFY2025 · Dec 31, 2025EPS (Basic)
1.31CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.31CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
149.30MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
149.30MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
196.29MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-75.21KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
197.43MCNYFY2025 · Dec 31, 2025Free Cash Flow
131.18MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
245.00MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
196.29MCNYFY2025 · Dec 31, 2025Other Non-cash Items
5.61MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-12.06MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
7.58MCNYFY2025 · Dec 31, 2025Capital Expenditures
-66.25MCNYFY2025 · Dec 31, 2025Purchase of Investments
-3.93BCNYFY2025 · Dec 31, 2025Sale of Investments
3.34BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-661.44MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.50MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-270.00KCNYFY2025 · Dec 31, 2025Common Dividends Paid
-49.50MCNYFY2025 · Dec 31, 2025Other Financing Charges
-5.84MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-54.11MCNYFY2025 · Dec 31, 2025Shares Outstanding
149.19MSharesUpdated Sep 21, 2026Float Shares
141.73MSharesUpdated Sep 21, 2026% Held by Insiders
47.25%vs all stocks
% Held by Institutions
7.38%vs all stocks
Total Cash (MRQ)
1.48BCNY220.80M · vs all stocks (USD)
Total Cash per Share (MRQ)
9.92CNYUpdated Sep 21, 2026Total Debt (MRQ)
9.71MCNY1.45M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0044xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
7.57xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
14.67CNYUpdated Sep 21, 2026Total Assets
2.46BCNY367.57M · vs all stocks (USD)
Total Current Assets
2.03BCNYFY2025 · Dec 31, 2025Total Liabilities
312.78MCNYFY2025 · Dec 31, 2025Total Non-current Assets
436.44MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
63.78MCNYFY2025 · Dec 31, 2025Total Current Liabilities
248.99MCNYFY2025 · Dec 31, 2025Cash
241.50MCNYFY2025 · Dec 31, 2025Cash Equivalents
7.52MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
249.02MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.21BCNYFY2025 · Dec 31, 2025Accounts Receivable
201.24MCNYFY2025 · Dec 31, 2025Inventory
141.75MCNYFY2025 · Dec 31, 2025Accounts Payable
147.16MCNYFY2025 · Dec 31, 2025Short-term Debt
5.16MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.53MCNYFY2025 · Dec 31, 2025Long-term Debt
7.42MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
36.15MCNYFY2025 · Dec 31, 2025Common Stock (Book)
106.56MCNYFY2025 · Dec 31, 2025Retained Earnings
675.19MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.15BCNY320.90M · vs all stocks (USD)
52-Week Low
29.77CNYUpdated Sep 21, 202652-Week High
87.98CNYUpdated Sep 21, 202652-Week Change
79.63%vs all stocks
Beta
0.9280xvs all stocks
50-Day MA
52.99CNYUpdated Sep 21, 2026200-Day MA
48.68CNYUpdated Sep 21, 2026Avg 10-Day Volume
5.52MSharesUpdated Sep 21, 2026Avg 30-Day Volume
6.06MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
1.40CNYUpdated Sep 21, 20267 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How does this company use capital?
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
Where is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 13.61: safe zoneNotable
Altman Z-Score: 13.61
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Caina Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Banco Products (India) Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Changzhou Galaxy Century Microelectronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Transformers and Rectifiers (India) Limited
Tier 1ProductionThroughput-Bound ConversionRuleFlow
United Renewable Energy Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Henan Hengxing Science Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Unitech Printed Circuit Board Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Quanex Building Products Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Anhui Tongfeng Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Reliance Power Ltd
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Medlive Technology Co. Ltd.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash Backing With Revenue And Income StreaksOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthLow-Leverage Liquidity Configuration
Shanghai Bochuan Electronic Co., Ltd.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash Backing With Revenue And Income StreaksOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthLow-Leverage Liquidity Configuration
Xi'an High Voltage Apparatus Co., Ltd.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash Backing With Revenue And Income StreaksOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthLow-Leverage Liquidity Configuration